US Patent Issued to Janssen Pharmaceuticals on April 15 for "MDR E. coli immunogen" (Austrian, Hungarian, Polish Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,742, issued on April 15, was assigned to Janssen Pharmaceuticals Inc..

"MDR E. coli immunogen" was invented by Eszter Nagy (Wein, Austria), Gabor Nagy (Sopron, Hungary), Valeria Szijarto (Vienna), Zoltan Magyarics (Vienna), Irina Mirkina (Vienna), Luis Gauchalla (Vienna), Adriana Badarau (Vienna), Gerhild Zauner (Vienna) and Jolanta Lukasiewicz (Wroclaw, Poland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmid...